CAS: 100999-26-6 - CY 208-243
Formula:C19H18N2
InChI:InChI=1S/C19H18N2/c1-21-11-12-5-2-3-6-14(12)19-15-7-4-8-16-18(15)13(10-20-16)9-17(19)21/h2-8,10,17,19-20H,9,11H2,1H3/t17-,19-/m1/s1
InChI key:InChIKey=WRNKIDLXXXIELU-IEBWSBKVSA-N
SMILES:C=1C=CC2=C(C1)CN(C)C3CC4=CNC5=CC=CC(=C54)C23
- Synonyms:
- (-)-(6Ar,12Br)-4,6,6A,7,8,12B-Hexahydro-7-Methylindolo[4,3-A]Phenanthridin
- (6aR,12bR)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-ab]phenanthridine
- (6aR,12bR)-7-methyl-4,6,6a,7,8,12b-hexahydroindolo[4,3-ab]phenanthridine
- Indolo[4,3-ab]phenanthridine, 4,6,6a,7,8,12b-hexahydro-7-methyl-, (6aR,12bR)-
- Indolo[4,3-ab]phenanthridine, 4,6,6a,7,8,12b-hexahydro-7-methyl-, (6aR-trans)-
- Indolophenanthridine
- CY 208-243
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CY 208-243 REF: 4Z-C-430001CAS: 100999-26-6 | - - - | To inquire | Tue 17 Dec 24 |
 | CY 208-243 REF: 3D-AEA99926CAS: 100999-26-6 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | CY 208-243 REF: TM-T10908CAS: 100999-26-6 | 98% | To inquire | Tue 11 Feb 25 |
Ref: 4Z-C-430001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
CY 208-243
CAS:100999-26-6
CY 208-243 is a selective dopamine D2 receptor agonist that has been shown to produce …
Formula:
C19H18N2
Purity:
Min. 95%
Molecular weight:
274.36 g/mol
Ref: 3D-AEA99926
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
CY 208-243
CAS:100999-26-6
CY 208-243 is a selective dopamine D1 receptor agonist with anti-Parkinson disease activity.
Formula:
C19H18N2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
274.36
Ref: TM-T10908
| 25mg | 712.00 € | ||
| 50mg | 929.00 € | ||
| 100mg | 1,454.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
